SCHEMBL5589074

SCHEMBL5589074

CCCCOc1c(O)c(O)c(CCC)c(CCC)c1OCCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.38
NR5A1 Q13285 1/20 0.38
CYSLTR2 Q9NS75 9/20 0.36
CYSLTR1 Q9Y271 9/20 0.36
GSTA1 P08263 1/20 0.35
GSTP1 P09211 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
NFKB1 P19838 1/20 0.35
PPARG P37231 1/20 0.35
BLM P54132 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
GRM2 Q14416 1/20 0.35
ALOX5 P09917 3/20 0.34
ESR1 P03372 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587609 0.93 HPGD (0.40) LTA4HNR5A1GSTA1GSTP1THRA
SCHEMBL5589063 0.93 LTA4H (0.38) LTA4HNR5A1CYSLTR2CYSLTR1THRA
SCHEMBL5589262 0.93 LTA4H (0.38) LTA4HNR5A1CYSLTR2CYSLTR1GSTA1
SCHEMBL5588965 0.91 ALOX5 (0.43) LTA4HNR5A1LMNAALOX5ESR1
SCHEMBL5589248 0.89 ALOX5 (0.45) LTA4HNR5A1LMNAALOX5ESR1
SCHEMBL5589062 0.89 ALOX5 (0.45) LTA4HNR5A1LMNAALOX5ESR1
SCHEMBL5587638 0.89 ALOX5 (0.45) LTA4HNR5A1LMNAALOX5ESR1
SCHEMBL5590671 0.89 ALOX5 (0.45) LTA4HNR5A1LMNAALOX5ESR1
SCHEMBL5590172 0.89 ALOX5 (0.45) LTA4HNR5A1LMNAALOX5ESR1
SCHEMBL5587400 0.89 CYSLTR2 (0.33) LTA4HCYSLTR2CYSLTR1GSTA1GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LTA4H 147/4885NR5A1 2413/4885CYSLTR2 797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.